Author

S.-H. Jiang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Q. Li· 2 shared B.-T. Li· 1 shared C. Jiang· 1 shared D.-J. Liu· 1 shared F. Dong· 1 shared H. Zhu· 1 shared H.-F. Yao· 1 shared J. CheniD· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Q. Li

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

SSRI antidepressant citalopram reverses the Warburg effect to inhibit hepatocellular carcinoma by directly targeting GLUT1

F. Dong, K. He, S. Zhang, K. Song, L. Jiang, L. Hu, Q. Li, X.-L. Zhang, N. Zhang, B.-T. Li, L.-L. Zhu, J. Li, M. Feng, Y. Gao, J. Chen, , S.-H. Jiang

This study identifies GLUT1 as a target of SSRIs, showing citalopram inhibits HCC by reversing the Warburg effect through GLUT1 antagonism.

Cell Reports · Oct 1, 2024Peer-reviewedCancer Biology

A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer

J.-H. Zheng, Y.-H. Zhu, J. Yang, P.-X. Ji, R.-K. Zhao, Z.-H. Duan, H.-F. Yao, Q.-Y. Jia, Y.-F. Yin, L.-P. Hu, Q. Li, S.-H. Jiang, Y.-M. Huo, W. Liu, Y.-W. Sun, D.-J. Liu

This study identifies CLIC1 as a key molecule linking matrix stiffness and the Warburg effect in pancreatic cancer, promoting tumor growth through ROS/HIF1 signaling.

bioRxiv · Oct 27, 2023Cancer Biology